Olso, Norway

Solvi Gunnes

This inventor holds 2 USPTO granted patents. Top assignee: C10 Pharma as. Active years: 2009-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Solvi Gunnes. Retrieved from https://idiyas.com/inventor/solvi-gunnes-qmt2suh5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Location History:

  • Oslo, NO (2009)
  • Olso, NO (2011)

Company Filing History:


Years Active: 2009-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Solvi Gunnes: Innovator in Macrolide Antibiotics

Introduction

Solvi Gunnes is a notable inventor based in Oslo, Norway. She has made significant contributions to the field of pharmaceuticals, particularly in the development of macrolide antibiotics. With a total of two patents to her name, her work is recognized for its potential impact on medical treatments.

Latest Patents

Gunnes's latest patents focus on 10-substituted macrolide antibiotics. These patents disclose the preparation, pharmaceutical compositions, and methods of treatment using 10-desmethyl, 10-substituted macrolides. The 10-desmethyl macrolides are particularly useful as antibiotics, showcasing their importance in combating bacterial infections.

Career Highlights

Throughout her career, Solvi Gunnes has demonstrated a commitment to innovation in the pharmaceutical industry. Her work at C10 Pharma AS has positioned her as a key player in the development of new antibiotic therapies. Her research is aimed at improving treatment options for patients, highlighting her dedication to public health.

Collaborations

Gunnes collaborates with Kjell Undheim, who is also a prominent figure in the field. Their partnership exemplifies the collaborative spirit often found in research and development, leading to advancements in antibiotic therapies.

Conclusion

Solvi Gunnes is a pioneering inventor whose work in macrolide antibiotics has the potential to transform medical treatments. Her contributions to the field are invaluable, and her ongoing research continues to inspire innovation in pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…